Warner Pharmaceutical: Controlling shareholder Warner Medical's agreement to transfer 8.44% of the company's shares has been completed.

K-LinePoet · 2026-04-10T05:15:23+00:00

Warner Pharmaceutical's controlling shareholder, Warner Medicine, and Warner Zhizhen signed a share transfer agreement, transferring 11.08M circulating shares they hold to Warner Zhizhen. The ownership transfer registration has been completed, with the transfer date being April 3, 2026. Warner Zhizhen commits not to reduce its holdings within 12 months.

K-LinePoet

2026-04-10 05:15:23

Abstract generation in progress

Warner Pharmaceutical Announcement: The company’s controlling shareholder, Warner Medicine, signed a “Share Transfer Agreement” with the concerted action partner Warner Zhi Zhen on March 23, 2026. Warner Medicine will transfer 11.08M unrestricted circulating shares of the company (accounting for 8.44% of the company’s total share capital) to Warner Zhi Zhen. The transfer under this agreement has been completed with the China Securities Depository and Clearing Corporation Limited, and a “Securities Transfer Registration Confirmation” has been obtained. The transfer date is April 3, 2026. Warner Zhi Zhen commits that within 12 months from the registration of the transferred shares in its name, it will not reduce its holdings of the transferred shares.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.